buprenorphine
Commercial- Indications
- Opioid use disorder, Pain
Company intelligence / Profile preview
River Stone Biotech
Wilmington, Delaware, United Statesriverstonebio.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
River Stone Biotech has developed a proprietary hybrid platform combining synthetic biology and traditional chemistry to produce specialty alkaloid APIs. The company’s lead products—buprenorphine, naloxone, and naltrexone—are approved by global regulatory authorities for opioid use disorder, alcohol use disorder, opioid overdose reversal, and pain. Their process reduces cost and environmental impact compared to traditional methods. The company is expanding its pipeline to include additional "Nal group" compounds[1][2][5][6].
- Therapeutic areas
- Metabolic DisordersPsychiatryNeurology
- Modalities
- Small moleculeSynthetic alkaloid (as a subset of small molecules)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Select global providers for virtual cross-functional operations[2]Open to industry/academic collaborations for generics partnerships[2]
Beyond the preview
Go deeper on River Stone Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on River Stone Biotech.